Actinium Pharmaceuticals Inc (ATNM)

Dec 11, 2024, 9:32 AM EST - 5 weeks ago

My Top 2 Stock Picks For A 2025 Rebound

AES

Nov 18, 2024, 7:00 PM EST - 2 months ago

SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player

Nov 18, 2024, 8:00 AM EST - 2 months ago

Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024

Nov 4, 2024, 11:00 AM EST - 2 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Nov 4, 2024, 7:30 AM EST - 2 months ago

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors

Nov 3, 2024, 11:00 AM EST - 2 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

Nov 2, 2024, 11:00 AM EDT - 2 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 30, 2024, 11:00 AM EDT - 2 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Violations Of Securities Laws And Affected Shareholders Should Contact The Schall Law Firm

Oct 29, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Actinium Pharmaceuticals Inc For Fraud

Oct 28, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

Oct 27, 2024, 11:00 AM EDT - 2 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 25, 2024, 11:00 AM EDT - 3 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 21, 2024, 11:00 AM EDT - 3 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 20, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Oct 19, 2024, 11:00 AM EDT - 3 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 18, 2024, 7:00 AM EDT - 3 months ago

Actineer, a Joint Venture of ITM and CNL, Begins Actinium-225 Production

Oct 16, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investors To Take Part In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Oct 14, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc's Possible Securities Fraud

Oct 9, 2024, 11:00 AM EDT - 3 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 8, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Oct 5, 2024, 11:00 AM EDT - 3 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Oct 2, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc's Possible Securities Fraud

Oct 1, 2024, 11:00 AM EDT - 3 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Stockholders With Losses Are Urged To Contact The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 3 months ago

TerraPower Isotopes Brings Actinium-225 to Market

Sep 30, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Sep 29, 2024, 11:00 AM EDT - 3 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Impacted Stockholders Are Urged To Reach Out To The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Sep 27, 2024, 11:00 AM EDT - 4 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Violating Securities Laws And Impacted Stockholders Are Urged To Contact The Schall Law Firm

Sep 26, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

Sep 25, 2024, 11:00 AM EDT - 4 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Sep 24, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Invites Investors To Join A Securities Fraud Inquiry Into Actinium Pharmaceuticals Inc

Sep 23, 2024, 11:00 AM EDT - 4 months ago

Actinium Pharmaceuticals, Inc. Is Being Investigated By The Schall Law Firm For Violating Securities Laws And Shareholders Should Reach Out

Sep 22, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Actinium Pharmaceuticals Inc For Possible Securities Fraud And Investors With Losses Are Urged To Join The Inquiry

Sep 21, 2024, 11:00 AM EDT - 4 months ago

Actinium Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Encourages Impacted Shareholders To Reach Out

Sep 20, 2024, 11:00 AM EDT - 4 months ago

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

Sep 20, 2024, 8:00 AM EDT - 4 months ago

Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology

Sep 19, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Actinium Pharmaceuticals, Inc.'s Possible Securities Law Violations And Stockholders With Losses Should Reach Out

Sep 18, 2024, 11:00 AM EDT - 4 months ago

Actinium Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm

Sep 17, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Actinium Pharmaceuticals, Inc. For Violating Securities Laws

Sep 16, 2024, 11:00 AM EDT - 4 months ago

Actinium Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Sep 15, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Wants Shareholders To Partake In An Inquiry Into Actinium Pharmaceuticals, Inc. For Securities Related Infractions

Sep 14, 2024, 11:00 AM EDT - 4 months ago

Actinium Pharmaceuticals Inc Is Being Investigated By The Schall Law Firm For Possible Fraud And Investors With Losses Should Reach Out

Sep 13, 2024, 11:00 AM EDT - 4 months ago

Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry In Actinium Pharmaceuticals, Inc. For Securities Law Violations

Sep 12, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Whether Actinium Pharmaceuticals Inc Committed Securities Fraud And Investors With Losses Can Reach Out

Sep 11, 2024, 11:00 AM EDT - 4 months ago

Stakeholders In Actinium Pharmaceuticals Inc. Are Encouraged To Contribute To The Schall Law Firm's Inquiry

Sep 11, 2024, 1:00 AM EDT - 4 months ago

IBA's joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production

Sep 10, 2024, 11:00 AM EDT - 4 months ago

Actinium Pharmaceuticals Inc May Have Violated Securities Regulations And The Schall Law Firm Invites Investors To Help With An Investigation

Sep 9, 2024, 11:00 AM EDT - 4 months ago

Shareholders Are Encouraged To Join The Schall Law Firm In An Inquiry Into Whether Actinium Pharmaceuticals, Inc. Committed Securities Fraud

Sep 7, 2024, 11:00 AM EDT - 4 months ago

Securities Laws May Have Been Violated By Actinium Pharmaceuticals Inc And The Schall Law Firm Invites Investors To Join An Investigation